Klebsiella infections in the immunocompromised host

Advances in Experimental Medicine and Biology

Volumn 479, Issue , 2000, Pages 237-249

  Sahly, H ^a   Podschun, R ^a   Ullmann, U ^a  

^a UNIVERSITY OF KIEL   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; BACTERIUM LIPOPOLYSACCHARIDE; POLYSACCHARIDE; SIDEROPHORE;

BACTERIAL MEMBRANE; BACTERIUM PILUS; CONFERENCE PAPER; DISEASE PREDISPOSITION; DISEASE TRANSMISSION; HUMAN; IMMUNE DEFICIENCY; INFECTION SENSITIVITY; KLEBSIELLA; PATHOGENICITY; PRIORITY JOURNAL;

ADHESINS, BACTERIAL; HUMANS; IMMUNOCOMPROMISED HOST; KLEBSIELLA; KLEBSIELLA INFECTIONS; VIRULENCE;

BACTERIA (MICROORGANISMS); KLEBSIELLA;

EID: 0034471053     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Conference Paper

References (72)

1. Biosynthesis of Klebsiella K2 capsule polysaccharide in Escherichia coli HB101 requieres the functions of rmpA and the chromosomal cps gene cluster of the virulent strain Klebsiella pneumoniae Chedid (O1:K2)
2. Effect of decreased salivation and pH on the adherence of Klebsiella species to human buccal epithelial cells
3. Predominance of certain klebsiella capsular types in hospitals in the United Kingdom
4. An endemic caused by multiresistant Klebsiella in an urological unit
5. Role of lipopolysaccharide and complement in susceptibility of Klebsiella pneumoniae to nonimmune serum
6. Enterobacterial fimbriae
7. Experimental Klebsiella pneumoniae burn wound sepsis: Role of capsular polysaccharide
8. Safety and immunogenicity of Klebsiella pneumoniae K1 capsular polysaccharide vaccine in humans
9. Seroepidemiology of Klebsiella bacteremic isolates and implications for vaccine development
10. R-plasmid-encoded adhesive factor in Klebsiella pneumoniae strains responsible for human nosocomial infections
11. Prospective survey of colonization and infection caused by extended spectrum-beta-lactamse-producing members of the family Enterobacteriacae in intensive care unit
12. A new fimbrial antigen harbored by CAZ-5/SHV-4-producing Klebsiella pneumoniae strains involved in nosocomial infections
13. Epidemics: Identification and management
14. Lobar pneumonia in rats produced by clinical isolates of Klebsiella pneumoniae
15. Adhesive propertien in Enterobacteriaceae
16. The pathogenicity of Klebsiella pneumoniae for mice: The relationship to the quantity and rate of production of type-specific capsular polysaccharide
17. Enterobacteriaceae
18. Effect of piliation on Klebsiella pneumoniae infection in rat bladders
19. Klebsiella pneumoniae-induced experimental pyelitis: The effect of piliation on infectivity
20. Aggregative adherence of Klebsiella pneumoniae to human Intestine-407 cells
21. Consequences of reduction of Klebsiella pneumoniae capsule expression on interaction of this bacterium with epithelial cells
22. N-Glycosylated proteins are involved in efficient internalization of Klebsiella pneumoniae by cultured human epithelial cells
23. Gram-negative bacteremia in non-neutropenic patients: A 3-year review
24. The iron-uptake systems of pathogenic bacteria
25. Klebsiella pneumoniae: Selected virulence factors that contribute to pathogenicity
26. Pathogens causing nosocomial infections
27. Adherence to respiratory epithelia by recombinant Escherichia coli expressing Klebsiella pneumoniae type 3 fimbrial gene products
28. 1997 Guidelines for the use of antimicrobial agents in neutropenic patients with unexplaned fever
29. Etiology of community-acquired pneumonia in hospitalized patients: A 3-year prospective study in Japan
30. Antimicrobial-resistant pathogens in the 1990s
31. More extended spectrum β-lactamases
32. Complement evasion by bacteria and parasites
33. Microbial iron-chelators and their action on Klebsiella infections in the skin of guinea-pigs
34. The use of colonization rate and epidemic index as tools to illustrate the epidemiology of faecal Enterobacteriaceae strains in swedish neonatal wards
35. Population shift in mannose-specific fimbriated phase of Klebsiella pneumoniae during experimental urinary tract infection in mice
36. Interventional anmtimicrobial therapy in febrile neutropenic patients
37. Expression of type 1 fimbriae and capsule in Klebsiella pneumoniae K21
38. The rcsA gene of O1:K20 is involved in expression of serotype-specific K (capsular) antigen
39. Mechanisms of Klebsiella pneumoniae resistance to complement-mediated killing
40. Enterobacterial chelators of iron: Their occurrence, detection, and relation to pathogenicity
41. Virulence for mice of Klebsiella strains belonging to the O1 group: Relationship to their capsule (K) types
42. MR/K hemagglutination of Providencia stuartii correlates with adherence to catheters and with persistence in catheter-associated bacteriuria
43. Epidemiology of Klebsiella and hospital-associated infections
44. Correlation of the virulence of Klebsiella pneumoniae K1 and K2 with the presence of a plasmid encoding aerobactin
45. Prevention of internalisation-associated gene, prtF1, among persisting group-A streptococcus strains isolated from asymptomatic carriers
46. Nosocomial infection caused by gentamicin-resistant, streptomycin-sensitive Klebsiella
47. Invasion of cultured human epithelial cells by Klebsiella pneumoniae isolated from the urinary tract
48. Nonopsonic phagocytosis of microorganisms
49. Serotyping of Klebsiella
50. Comparative investigations of Klebsiella species of clinical origin: Plasmid patterns, biochemical reactions, antibiotic resistances and serotypes
51. Interaction of Klebsiella capsule type 7 with human polymorphonuclear leucocytes
52. Serotypes, hemagglutinins, siderophore synthesis, and serum resistance of Klebsiella isolates causing human urinary tract infections
53. Isolation of Klebsiella terrigena from clinical specimens
54. Klebsiella capsular type K7 in relation to toxicity, susceptibility to phagocytosis and resistance to serum
55. Incidence of Klebsiella planticola among clinical Klebsiella isolates
56. Klebsiella spp. as nosocomial pathogen: Epidemiology, taxonomy, typing methods, and pathogenicity factors
57. Selective pressures and lipopolysaccharide subunits as determinants of resistance of clinical isolates of gram-negative bacilli to human serum
58. Klebsiella pneumoniae pneumonia
59. Combined biochemical and serological typing of clinical isolates of Klebsiella
60. Klebsiella capsular type versus site of isolation
61. Infection and colonization of an intensive care unit patient's respiratory tract by a Klebsiella pneumoniae strain producing an novel AmpC-type β-lactamase different from that known
62. Clinical, serological, and epidemiological aspects of Klebsiella infections and their spondylarthropathic sequelae
63. Chemiluminescence of human leucocytes stimulated by clinical isolates of Klebsiella
64. The role of K antigens as virulence factors in Klebsiella
65. Binding of the type 3 fimbriae of Klebsiella pneumoniae to human endothelial and urinary bladder cells
66. Role of capsule and O antigen in resistance of Klebsiella pneumoniae to serum bactericidal activity
67. Severe community acquired pneumonia; epidemiology and prognostic factors
68. Pattern of microbial isolates in hospitalized patients
69. The role of the O and K antigens in determining the resistance of Klebsiella aerogenes to serum killing and phagocytosis
70. The pathogenicity of Klebsiella pneumoniae
71. Type of fimbriation determines adherence of Klebsiella bacteria to human epithelial cells